Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¿ìÀ¯ °ú¹Î¼º À庴Áõ(cow¡¯s milk-sensitive enteropathy)ÀÇ Àå±â ÃßÀû°üÂû A Follow-Up Study of Cow¡¯s Milk-Sensitive Enteropathy: Clinical Outcome

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2001³â 4±Ç 1È£ p.47 ~ 53
¼Û¾Ö·É, ÃÖÀºÁø, ÇÑâȣ, Á¤Çý¸®, ±Ç¿µ´ë, ȲÁøº¹,
¼Ò¼Ó »ó¼¼Á¤º¸
¼Û¾Ö·É ( Song Ae-Ryong ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

ÃÖÀºÁø ( Choi Eun-Jin ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ÇÑâȣ ( Han Chang-Ho ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
Á¤Çý¸® ( Chung Hai-Lee ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
±Ç¿µ´ë ( Kwon Young-Dae ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç
ȲÁøº¹ ( Hwang Jin-Bok ) 
´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ¼Ò¾Æ°úÇб³½Ç

Abstract

¸ñ Àû: ¿ìÀ¯ °ú¹Î¼º À庴Áõ(cow¡¯s milk-sensitive enteropathy, CMSE)Àº ±Û·çÅÙ °ú¹Î¼º À庴Áõ°ú´Â ´Þ¸® ÀϽÃÀûÀÎ ÁúȯÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. CMSEÀÇ Àå±â ÃßÀû°üÂûÀ» ÅëÇÏ¿© ¿ìÀ¯ ¹× Ÿ À½½Ä¿¡ ´ëÇÑ ³»¼º ½Ã±â, ¹ßÇö Áõ»ó, ¾Ë·¹¸£±â Áúȯ µ¿¹Ý À¯¹«, °¡Á··Â µîÀ» ÆľÇÇÏ¿© ȯÀÚ¿¡ ´ëÇÑ ¿¹Èļ³¸í, ¼öÀ¯¹æ¹ýÀÇ º¯È­½Ã±â¿Í ÀÌÀ¯½ÄÀÇ ÀÌ¿ë µî ÇâÈÄ ½ÄÀÌ Á¶Àý¿¡ ´ëÇÑ ÁöħÀ» ¸¶·ÃÇÏ°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

´ë»ó ¹× ¹æ¹ý: 1992³â 3¿ùºÎÅÍ 1997³â 3¿ù±îÁö ´ë±¸°¡Å縯´ëÇк´¿ø ¼Ò¾Æ°ú¿¡¼­ ¼ºÀåÀå¾Ö¿Í ¼³»ç¸¦ ÁÖ¼Ò·Î ³»¿øÇÏ¿©, ¿ìÀ¯ À¯¹ß ¹× Á¦°Å½ÃÇè, ¼ÒÀå »ý°ËÁ¶Á÷ÀÇ ÇüÅÂÇÐÀû °èÃøÀ» ÅëÇÏ¿© CMSE·Î Áø´Ü¹ÞÀº ÈÄ ÃßÀû °üÂû°ú ÀüÈ­ ¼³¹®ÀÌ °¡´ÉÇÏ¿´´ø 21¸íÀ» ´ë»óÀ¸·Î ÇÏ¿´´Ù. ÀÔ¿ø´ç½Ã ¿¬·ÉÀº 30.7 8.8 (18¡­47)ÀÏ, ¼³¹®´ç½Ã´Â 43.4 23.7 (16¡­84)°³¿ùÀÌ¿´´Ù. »ýÈÄ 6°³¿ù±îÁö´Â Àý´ëÀûÀ¸·Î ´Ü¹é°¡¼öºÐÇع°À» ¼öÀ¯ÇÏ°Ô ÇÏ¿´À¸¸ç, ÃßÈÄ 2°³¿ù °£°ÝÀ¸·Î À¯¹ß½ÃÇèÀ» ½ÃÇàÇÏ´Â Ä¡·á °èȹ¼­¸¦ ÀÛ¼º ÀÌ¿ëÇÏ¿´´Ù.

°á °ú:
1) ¿ìÀ¯¸¦ ¸Ô¿©µµ ³»¼ºÀ» º¸¿´´ø ÃÖÁ¾ ¿¬·ÉÀº 12.6 3.7 (6¡­24)°³¿ùÀ̾ú´Ù.
2) ³ªÀÌ¿¡ ÀûÇÕÇÑ ½ÄÀÌ °¡´ÉÇÑ ¸ðµç ½ÄÇ°¿¡ ³»¼ºÀ» º¸¿´´ø ¿¬·ÉÀº 15.5 3.7 (10¡­24)°³¿ùÀ̾ú´Ù.
3) ¿ìÀ¯ À¯¹ß½ÃÇè¿¡ µû¶ó °üÂûµÈ À¯ÇعÝÀÀ 19ȸ Áß ±¸Åä(31%), ¼³»ç(31%), º¸Ã¨ ȤÀº ±â¸é(21%), ¹ßÁø(10%), º¹ºÎÆظ¸(5%)ÀÇ Áõ¼¼¸¦ º¸¿´´Ù.
4) ÀÔ¿ø´ç½Ã Ç÷Áß IgE¿Í ¿ìÀ¯ RAST¿¡ ¾ç¼ºÀ» º¸ÀÎ 5¸í°ú À½¼ºÀ» º¸¿´´ø 16¸íÀ» ºñ±³ÇÏ¿© ¿ìÀ¯ ¹× Ÿ ½ÄÇ°¿¡ ´ëÇÑ ³»¼º ½Ã±â(p£¾0.05), Ÿ ¾Ë·¹¸£±â ÁúȯÀÇ ¹ßÇö À¯¹«, ¾Ë·¹¸£±â °¡Á··Â¿¡¼­ ÀÇ¹Ì ÀÖ´Â
Â÷ÀÌ°¡ °üÂûµÇÁö ¾Ê¾Ò´Ù.

°á ·Ð: CMSE´Â 2¼¼ À̳»¿¡ ÀÓ»óÀûÀ¸·Î ¿ÏÀüÇÑ È¸º¹À» º¸ÀδÙ. ¿ìÀ¯¿¡ ´ëÇÏ¿© 61%¿¡¼­ 1¼¼±îÁö, Àü·Ê¿¡¼­ 2¼¼ Àü±îÁö ³»¼ºÀ» º¸¿© ¿µÀ¯¾Æ±âÀÇ ÀϽÃÀû ÁúȯÀ¸·Î ÆǴܵȴÙ. Ÿ ½ÄÇ°¿¡ ´ëÇÑ ¾Ë·¹¸£±â ¹ßÇöÀº ƯÁ¤ À½½Äº¸´Ù´Â °³Àο¡ µû¸¥ ´Ù¾çÇÑ À½½Ä¹°¿¡¼­ ¹ß»ýÇϸç,Àü·Ê¿¡¼­ 2¼¼±îÁö ³»¼ºÀ» º¸ÀδÙ. Áø´Ü ´ç½Ã ¿ìÀ¯ RAST, Ç÷Áß IgEÀÇ »ó½Â°ú ¿ìÀ¯ ¹× Ÿ ½ÄÇ°¿¡ ´ëÇÑ ³»¼ºÀÇ ¹ßÇö ½Ã±â¿Í´Â ¹«°üÇÏ´Ù.

Purpose: Following up the cases of cow¡¯s milk-sensitive enteropathy (CMSE), We observed the development of clinical tolerance with cow¡¯s milk and other foods. We investigated the clinical outcome of CMSE.

Methods: We reviewed the clinical records of patients who had been admitted and diagnosed as CMSE by responses to cow¡¯s milk challenge and elimination test and the findings of small intestinal biopsy at Department of Pediatrics, Taegu Catholic University Hospital from March 1992 to March 1997. All of them were being fed with protein hydrolysate before 6 months old, and tried cow¡¯s milk and other foods challenge test at following each two month. Twenty-one cases of them returned t be followed. The age at admission was 30.7 8.8 (18¡­47) days old and at survey was 43.4 23.7 (16¡­84) months old.

Results: 1) Although the body weight at birth of the patients was 25¡­75 percentile, all on admission was below 3 percentile. The body weight on interview was 25¡­75 percentile. 2) The development of clinical tolerance in cow¡¯s milk was observed at 16¡­24 months of age and the tolerance rate was 61% at 12 months of age, 90% at 16 months of age. The development of clinical tolerance in other foods was observed at 10¡­24 months of age and the tolerance rate was 33% at 12 months of age, 80% at 18 months of age. 3) Adverse reactions after challenge test with cow¡¯s milk were observed at 19 cases, manifestated as vomiting (31%), diarrhea (31%), irritability or lethargy (21%), skin rash (10%), and abdominal distention (5%). 4) Comparing serum IgE and milk RAST positive group on admission (5 cases) and negative group on admission (16 cases), there was no significant difference at the age of tolerance in cow¡¯s milk (p£¾0.05), the age of tolerance in other foods (p£¾0.05), allergy history in family, and the incidence of other allergic diseases. 5) The history of family allergy was observed in 3 cases (14%) in 21 patients and 3 cases (14%) showed rhinitis, urticaria or asthma through a follow-up interview.

Conclusion: The development of clinical tolerance in cow¡¯s and other foods was sharply increased at 12 months of age and most of all tolerated within 24 months of age. CMSE is a temporary disorder of infancy.

Å°¿öµå

Cow¡¯s milk-sensitive enteropathy;Clinical outcome;Tolerance;Follow up;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS